Early prediction of blonanserin response in Japanese patients with schizophrenia

BACKGROUND: Blonanserin is a second-generation antipsychotic used for the treatment of schizophrenia in Japan and Korea. The present study aimed to examine early prediction of blonanserin in patients with schizophrenia. METHODS: An 8-week, prospective, single-arm, flexible-dose clinical trial of blo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kishi, Taro, Matsuda, Yuki, Fujita, Kiyoshi, Iwata, Nakao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181750/
https://www.ncbi.nlm.nih.gov/pubmed/25285009
http://dx.doi.org/10.2147/NDT.S70227

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181750/
https://www.ncbi.nlm.nih.gov/pubmed/25285009
http://dx.doi.org/10.2147/NDT.S70227

Ejemplares similares